HLS in Canada is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
For Canadian Residents looking to access commercial product information, please click on the product name in the table below
|Vascepa||CV risk reduction||Canada||Marketed|
|Trinomia||CV risk reduction||Canada||Under review|
|CENTRAL NERVOUS SYSTEM (CNS)|
|CSAN Pronto||WBC Point-of-Care Testing||Canada||Marketed|
|PERSERIS||Schizophrenia||Canada||Approved and in pre-launch phase|
|MyCare Psychiatry / MyCare Insite||Psychiatric Therapeutic Drug Monitoring||Canada||Approved and in pre-launch phase / under review|
|Royalty Portfolio||Multiple Indications||Global||Marketed by third parties|
For U.S. Residents, click on the American flag above for more commercial product information.